Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Acura Pharmaceuticals Total Assets (Quarterly): 1.406M for Sept. 30, 2021
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.86M |
| September 30, 2021 | 1.406M |
| June 30, 2021 | 1.896M |
| March 31, 2021 | 1.918M |
| December 31, 2020 | 1.736M |
| September 30, 2020 | 2.199M |
| June 30, 2020 | 2.536M |
| March 31, 2020 | 2.004M |
| December 31, 2019 | 2.562M |
| September 30, 2019 | 2.466M |
| June 30, 2019 | 2.453M |
| March 31, 2019 | 1.939M |
| December 31, 2018 | 2.152M |
| September 30, 2018 | 2.282M |
| June 30, 2018 | 2.813M |
| March 31, 2018 | 3.048M |
| December 31, 2017 | 4.604M |
| September 30, 2017 | 7.269M |
| June 30, 2017 | 6.24M |
| March 31, 2017 | 8.856M |
| December 31, 2016 | 8.208M |
| September 30, 2016 | 7.738M |
| June 30, 2016 | 10.22M |
| March 31, 2016 | 14.42M |
| December 31, 2015 | 16.96M |
| Date | Value |
|---|---|
| September 30, 2015 | 18.94M |
| June 30, 2015 | 14.96M |
| March 31, 2015 | 17.87M |
| December 31, 2014 | 16.03M |
| September 30, 2014 | 19.28M |
| June 30, 2014 | 21.86M |
| March 31, 2014 | 24.86M |
| December 31, 2013 | 28.63M |
| September 30, 2013 | 21.76M |
| June 30, 2013 | 21.50M |
| March 31, 2013 | 25.24M |
| December 31, 2012 | 29.06M |
| September 30, 2012 | 30.91M |
| June 30, 2012 | 32.84M |
| March 31, 2012 | 34.64M |
| December 31, 2011 | 37.17M |
| September 30, 2011 | 39.09M |
| June 30, 2011 | 41.10M |
| March 31, 2011 | 22.95M |
| December 31, 2010 | 25.49M |
| September 30, 2010 | 27.39M |
| June 30, 2010 | 28.93M |
| March 31, 2010 | 30.32M |
| December 31, 2009 | 31.92M |
| September 30, 2009 | 34.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.86M
Minimum
Dec 2021
2.562M
Maximum
Dec 2019
2.003M
Average
2.004M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.271M |
| Shareholders Equity (Quarterly) | 0.135M |